# Meditrina

> Meditrina designs and markets Aveta, an integrated hysteroscopy platform for diagnosing and removing tissue inside the uterus. Its single-use scopes use expandable working channels to pair narrow insertion diameters with larger resecting tools, while one controller brings video, tissue removal, and fluid management together for gynecologists in operating rooms and offices.

- **Founded:** 2016
- **Headquarters:** San Jose, United States
- **Founders:** Csaba Truckai (Founder and CEO)
- **Products:** Aveta System, Aveta Coral, Aveta Pearl, Aveta Office Suite and Auto, Aveta System 2.0 and Glo
- **Notable:** Aveta received U.S. FDA 510(k) clearance in May 2019 and launched at the 2019 AAGL meeting., Aveta Office Suite was released in 2021., Aveta System 2.0 and Glo bipolar RF device received FDA 510(k) clearance announced in May 2024.

## Products & services

- **Aveta System** — Integrated hysteroscopy platform combining HD visualization, tissue resection, and fluid management on one controller and monitor.
- **Aveta Coral** — Single-use hysteroscope with 4.6 mm insertion diameter and 3 mm working channel.
- **Aveta Pearl** — Single-use hysteroscope with 5.7 mm insertion diameter and 4 mm working channel.
- **Aveta Office Suite and Auto** — Office-oriented scope and motorized resecting device with suction pump and specimen container in the handle.
- **Aveta System 2.0 and Glo** — Second-generation system and bipolar RF resection device; FDA 510(k) clearance announced in 2024.
- **Aveta Smol, Flex+, and Max+** — Single-use resection devices optimized for tissue ranging from polyps to dense fibroids.

## Achievements

- Aveta received U.S. FDA 510(k) clearance in May 2019 and launched at the 2019 AAGL meeting.
- Aveta Office Suite was released in 2021.
- Aveta System 2.0 and Glo bipolar RF device received FDA 510(k) clearance announced in May 2024.
- Aveta received CE and UKCA marks and initial cases were performed in Spain and Denmark in 2024.
- M.E.D. Surgical distribution agreement expanded access to the UK and Ireland in 2025.

## Latest updates

- **2026-08** — Janis Smith-Gomez joined Meditrina's board of directors.
- **2025-10** — Meditrina announced a webinar comparing major hysteroscopic systems and linked a narrated Aveta myomectomy video.
- **2025-07** — M.E.D. Surgical became Aveta's distributor for Ireland and the UK.
- **2024-05** — Meditrina announced FDA clearance for Aveta System 2.0 and Glo, CE and UKCA marks, and the final tranche of a $77 million Series C.

## Links

- Website: https://www.avetasystem.com/
- LinkedIn: https://www.linkedin.com/company/meditrinainc
- Twitter/X: https://twitter.com/avetasystem
- Instagram: https://www.instagram.com/avetasystem/

---

Profile page: https://yespress.io/meditrina
Published by YesPress — https://yespress.io
Last updated: 2026-09-29